Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA

Virology

Volumn 237, Issue 2, 1997, Pages 270-282

  Kumar, P K R ^c   Machida, Keigo ^a   Urvil, Petri T ^c   Kakiuchi, Nobuko ^b   Vishnuvardhan, Daesety ^c   Shimotohno, Kunitada ^b   Taira, Kazunari ^a   Nishikawa, Satoshi ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; PROTEINASE; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; RNA VIRUS; VIRUS REPLICATION;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0030719462     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8773     Document Type: Article

References (56)

1. Bartenschlager R. L., Ahlborn-Laake L., Mous J., Jacobsen H. Kinetic and structural analysis of hepatitis C virus polyprotein processing. J. Virol. 68:1994;5045-5055.
2. Bartenschlager R., Lohman V., Wilkinson T., Koch J. O. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J. Virol. 69:1995;7519-7528.
3. Brown D., Gold L. Selection and characterization of RNAs replicated by Qβ replicase. Biochemistry. 34:1995;14765-14774.
4. Chambers T. J., Hahn C. S., Galler R., Rice C. M. Production of yellow fever virus proteins in infected cells: Identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. Virology. 177:1990;159-174.
5. Choo Q.-L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
6. Collett M. S. Molecular genetics of pestiviruses. Comp. Immunol. Microbiol. Infect. Dis. 15:1992;145-154.
7. Conrad R., Keranen L. M., Ellington A. D., Newton A. C. Isozyme-specific inhibition of protein kinase C by RNA aptamers. J. Biol. Chem. 269:1994;32051-32054.
8. Conrad R. C., Giver L., Tian Y., Ellington A. D. In vitro. Methods in Enzymology. 1996;Academic Press, San Diego. p. 336-367.
9. Ellington A. D., Szostak J. W. Selection of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature. 355:1992;850-852.
10. Failla C., Tomei L., De Francesco R. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J. Virol. 68:1994;3753-3760.
11. Failla C., Tomei L., DeFrancesco R. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J. Virol. 69:1995;1769-1777.
12. Francki R. I. B., Fauquet C. M., Knudson D. L., Brown F. Classification and nomenclature of viruses: Fifth report of the International Committee on Taxonomy of Viruses. Arch. Virol. 117:1991;223.
13. Gold L. Oligonucleotides as research, diagnostic, and therapeutic agents. J. Biol. Chem. 270:1995;13581-13584.
14. Gold L., Polisky B., Uhlenbeck O., Yarus M. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64:1995;763-797.
15. Grakoui A., Wyochowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993a;1385-1395.
16. Grakoui A., McCourt D. W., Wychowski C., Feinstgone S. M., Rice C. M. Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67:1993b;2832-2843.
17. Hahm B., Han D. S., Back S. H., Song O.-K., Cho M.-J., Kim C.-J., Shimotohno K., Jang S. K. NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J. Virol. 69:1995;2534-2539.
18. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome byin vitro. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
19. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67:1993;4665-4675.
20. Hirowatari Y., Hijikata M., Tanji Y., Nyunoya H., H. Mizushima H., Kimura K., Tanaka T., Kato N., Shimotohno K. Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vector. Arch. Virol. 133:1993;349-356.
21. M. Houghton, 1996, Hepatitis C viruses, Virology, 1035, 1058, Raven Press, New York.
22. Jaeger J. A., Turner D. H., Zuker M. Predicting optimal and suboptimal secondary structure for RNA. Methods in Enzymology. 1989;Academic Press, San Diego. p. 281-306.
23. Jellinek D., Green L. S., Bell C., Janjinc N. Inhibition of binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry. 33:1994;10450-10456.
24. Jeoung Y.-H., Kumar P. K. R., Suh Y.-A., Taira K., Nishikawa S. Identification of phosphate oxygens that are important for self-cleavage activity of the HDV ribozyme by phosphorothioate substitution interference analysis. Nucleic Acids Res. 22:1994;3722-3727.
25. Jin L., Peterson D. L. Expression, isolation and characterization of the hepatitis C virus ATPase/RNA helicase. Arch. Biochem. Biophys. 323:1995;47-53.
26. Kakiuchi N., Hijikata M., Komoda Y., Tanji Y., Hirowatari Y., Shimotohno K. Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrates. Biochem. Biophys. Res. Commun. 210:1995;1059-1065.
27. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;9524-9528.
28. Kim D. W., Gwack Y., Han J. H., Choe J. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem. Biophys. Res. Commun. 215:1995;160-166.
29. Kubik M. F., Stephens A. W., Schneider D. A., Marlar R., Tassett D. High-affinity RNA ligands to human α-thrombin. Nucleic Acids Res. 22:1994;2619-2626.
30. Kuo G., Choo Q.-L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Deinstag J. L., Alter M. J., Stevens C. E., Tegtmeier G. E., Bonino F., Colombo M., Lee W.-S., Kuo C., Berger K., Shuster J. R., Overby L. R., Bradley D. W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
31. Lain S., Riechmann J. L., Martin M. T., Garcia J. A. Homologous potyvirus and flavivirus proteins belonging to helicase-like proteins. Gene. 82:1989;357-362.
32. Leung D. W., Chen E., Goeddel D. V. A method for random mutagenesis of a defined DNA segment using a modified polymerase chain reaction. J. Methods Cell Mol. Biol. 1:1989;11-15.
33. Lin C., Lindenbach B. D., Pragai B., McCourt D. W., Rice C. M. Processing of the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini. J. Virol. 68:1994a;5063-5073.
34. Lin C., Pragai B. M., Grakoui A., Xu J., Rice C. M. Hepatitis C virus NS3 serine protease:Trans. J. Virol. 68:1994b;8147-8157.
35. Lin C., Rice C. M. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: Establishment of a cell-freetrans. Proc. Natl. Acad. Sci. USA. 92:1995;7622-7626.
36. Lin C., Thomson J. A., Rice C. M. A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complexin vivoin vitro. J. Virol. 69:1995;4373-4380.
37. Linder P., Lasko P. F., Leroy P., Nielsen P. J., Nishi K., Schnier J., Slonimski P. P. Birth of the D-E-A-D box. Nature. 337:1989;121-122.
38. Love R. A., Parge H. E., Wickersham J. A., Hostomsky Z., Habuka N., Moomaw E. W., Adachi T., Hostomska Z. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell. 87:1996;331-342.
39. Mizushima H., Hijikata M., Tanji Y., Kimura K., Shimotohno K. Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J. Virol. 68:1994a;2731-2734.
40. Mizushima H., Hijikata M., Asabe S. I., Hirota M., Kimura K., Shimotohno K. Two hepatitis C virus glycoprotein E2 products with different C termini. J. Virol. 68:1994b;6215-6222.
41. Morgenstern K. A., Landro J. A., Hsiao K., Lin C., Gu Y., Su M. S.-S., Thomson J. A. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J. Virol. 71:1997;3767-3775.
42. Rice C. M. Flaviviridae: The viruses and their replication. Fields B. N., Knipe D. M., Howley P. M. Virology. 1996;931-960 Raven Press, New York.
43. Sakamoto M., Akahane Y., Tsuda F., Tanaka T., Woodfield D. G., Okamoto H. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J. Gen. Virol. 75:1994;1761-1768.
44. Satoh S., Tanji Y., Hijikata M., Kimura K., Shimotohno K. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J. Virol. 69:1995;4255-4260.
45. Shimizu Y., Yamaji K., Masuho Y., Yokota T., Inoue H., Sudo K., Satho S., Shimotohno K. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J. Virol. 70:1996;127-132.
46. Shimotohno K. Hepatocellular carcinoma in Japan and its linkage to infection with hepatitis C virus. Semin. Virol. 4:1993;305-312.
47. Suzich J. A., Tamura J. K., Palmer-Hill F., Warrener P., Grakoui A., Rice C. M., Feinstone S. M., Collett M. S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatse and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 67:1993;6152-6158.
48. Tai C.-L., Chi W.-K., Chen D.-S., Hwang L.-H. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J. Virol. 70:1996;8477-8484.
49. Tanaka T., Kato N., Nakagawa M., Ootsuyama Y., Cho M.-J., Nakazawa T., Hijikata M., Ishimura Y., Shimotohno K. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: Sequence variation within the same individual and among infected individuals. Virus Res. 23:1992;39-53.
50. Tanji Y., Hijikata M., Hirowatari Y., Shimotohno K. Identification of the domain required fortrans. Gene. 145:1993;215-219.
51. Tanji Y., Hijikata M., Satoh S., Kaneko T., Shimotohno K. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J. Virol. 69:1995;1575-1581.
52. Tomei L., Failla C., Santolini E., De Francesco R., La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67:1993;4017-4026.
53. Tuerk C., MacDougal S., Gold L. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA. 89:1992;6988-6992.
54. Uphoff K. W., Bell S. D., Ellington A. D. In vitro. Curr. Opin. Struct. Biol. 6:1995;281-288.
55. Urvil P. T., Kakiuchi N., Zhou D-.M., Shimotohno K., Kumar P. K. R., Nishikawa S. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. Eur. J. Biochem. 248:1997;130-138.
56. Vishnuvardhan D., Kakiuchi N., Urvil P. T., Shimotohno K., Kumar P. K. R., Nishikawa S. Expression of highly active recombinant NS3 protease domain of hepatitis C virus inE. coli. FEBS Lett. 402:1997;209-212.